CD79A and autoimmune disease: Regular monitoring of IgA levels is necessary, with attention to the potential for normalization; however, ongoing follow-up is crucial due to the risk of progression to other immunodeficiencies, the development of autoimmune diseases, and vigilance for neoplasms.